SM-2 Use of a standard process for assessing ASCVD risk CDU To facilitate decisions about preventive interventions, it is recommended to screen for traditional ASCVD risk factors and apply the race- and sex-specific PCE (ASCVD Risk Estimator) to estimate 10-year ASCVD risk for asymptomatic adults 40 79 years of age. SM-3 Use of a standard process for properly screening all adults 18 y of age for HBP CDU The evidence on the benefits of screening for HBP is well established. In 2007, the USPSTF reaffirmed its 2003 recommendation to screen for HBP in adults 18 y of age. SM-4 Use of an EHR to accurately diagnose and assess HBP control CDU A growing number of health systems are developing or using registries and EHRs that permit large-scale queries to support population health management strategies to identify undiagnosed or undertreated HBP. SM-5 Use of a standard process to engage patients in shared decision-making, tailored to their personal benefits, goals, and values for evidence-based interventions to improve control of HBP CDU Decisions about primary prevention should be collaborative decisions made between a clinician and a patient. SM-6 Demonstration of infrastructure and personnel that assess and address social determinants of health of patients with HBP CDU It is important to tailor advice to an individual s socioeconomic and educational status, as well as cultural, work, and home environments. SM-7 Use of team-based care to better manage HBP CDU RCTs and meta-analyses of RCTs of team- based HBP care involving nurse or pharmacist intervention demonstrated reductions in SBP and DBP and/or greater achievement of BP goals when compared with usual care. 